Moptim presented its advanced Optical Coherence Tomography (OCT) solutions at the 2026 Brain Health Conference in Shanghai, demonstrating how high-resolution retinal imaging serves as a non-invasive window for early neuro-vascular risk assessment.

Featured in the "Future Brain Health Home" exhibit led by Beijing Tiantan Hospital, Moptim demonstrated its micro-resolution optical technology within a multi-tiered care model connecting clinical, community, and home care environments.

Connecting Ophthalmic Precision to Brain Health

The retina is the only anatomical site where neural tissue and blood vessels can be visualized non-invasively. Leveraging its core optical architecture, Moptim is expanding its spectral-domain and swept-source OCT/OCTA platforms beyond traditional ophthalmology into neurological disease screening and systemic cardiovascular risk management.

Through high-speed, non-invasive 3D scanning, Moptim’s OCTA systems capture subtle microvascular changes and structural neural alterations. This technology offers clinicians objective, quantifiable data for early risk stratification in cerebrovascular conditions and neurodegenerative disorders.

Validating Technology Through National Research Partnerships

As a member of the Tiantan Brain Health Innovation Alliance, Moptim is advancing clinical research and technology deployment across primary and community care networks.

Moptim serves as a core technical partner in a national major research initiative led by Beijing Tiantan Hospital, focused on digital prevention strategies for ischemic cerebrovascular disease. By combining research-grade imaging performance with optimized operational workflows, Moptim’s Mocean series wide-field OCTA platforms are currently deployed at Beijing Tiantan Hospital and community healthcare sites to collect real-world data for brain health diagnostic models.

Moptim will continue deepening its collaboration with clinical, academic, and research institutions. By integrating precision retinal imaging into broader brain health screening frameworks, Moptim remains committed to making advanced diagnostic tools accessible to healthcare systems worldwide.